On this episode, our guest is economist Paul Kohlhaas, co-founder and CEO of Molecule and co-author of the VitaDAO whitepaper. We’ll head to Berlin, Germany, where Paul and his team of scientists, engineers, entrepreneurs and enthusiasts who are designing new ways to advance medicines. In Molecule’s case, they’re using tools not from the lab, but [...]
The development of brain-machine or brain-computer interfaces (BCIs) approaches an […]
At the center of every clinical trial is a group […]
What does the future of scientific computing look like? Labs […]
Drugs are getting smarter. A new wave of companies, including […]
Drug discovery is changing. Deep generative models, as being pioneered […]
